Violent Lips makes pouts ‘sparkle’ with new line of temporary lip tattoos
NEW YORK — After seasons of sparkle nails, Violent Lips is putting the trend front and center with Glitteratti temporary lip tattoos.
Available exclusively at Sephora in five shades — red, pink, gold, silver and blue — each Glitteratti temporary lip tattoo offers sparkles that promise to stay put.
Violent Lips temporary lip tattoos are FDA-approved, vegan skin-safe transfers, tested on supermodels, not animals, and made in America, the company stated.
How it works: Shape, size and apply the Glitteratti Lips Appliqués with the mouth open wide to the “Oh” shape. Use plenty of water when applying and wet the lips after they are on to seal and smooth. The base of the Glitteratti line is clear so each color will have a slight variation when applied brought forth by the natural lip color. The patent-pending appliqué can be removed with mineral or baby oil and a textured wipe.
A set of three is priced at $15.95.
Triple Double Oreo officially makes debut
EAST HANOVER, N.J. — After news spread that the Triple Double Oreo was coming to store shelves nationwide, Oreo officially has launched its latest creation.
Triple Double Oreo, a sandwich cookie that features three pieces of chocolate wafers that are separated by chocolate and vanilla cream, is available nationwide at grocery stores for a suggested retail price of $4.19 per package. One serving (or one cookie) is 100 calories and touts a total of 4.5-g of fat.
"Our fans’ passion and enthusiasm has challenged us to raise our game," Kraft Foods associate director of consumer engagement Jessica Robinson said. "With the Triple Double Oreo cookie, we set out to take OREO to another level by adding a new twist. We are looking forward to engaging with Oreo fans as they share their twisting, licking and dunking moments with the new Triple Double Oreo cookie."
Mylan seeks approval for generic migraine drug
PITTSBURGH — Mylan announced Wednesday that it filed with the Food and Drug Administration for approval of a generic version of a drug for migraine headaches made by Endo Pharmaceuticals.
Mylan said it was the first to file for approval of a generic version of Frova (frovatriptan succinate EQ) tablets in the 2.5-mg strength. In response, Endo has filed a patent infringement lawsuit against Mylan in response to the filing.
Frova had sales of $68.2 million during the 12-month period ended in June, according to IMS Health.